Hospital at Home (HAH) for palliative care: an evaluation
| ISRCTN | ISRCTN75865015 |
|---|---|
| DOI | https://doi.org/10.1186/ISRCTN75865015 |
| Secondary identifying numbers | PSI10-19 |
- Submission date
- 23/01/2004
- Registration date
- 23/01/2004
- Last edited
- 21/12/2009
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Other
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Plain English summary of protocol
Not provided at time of registration
Contact information
Dr Chris Todd
Scientific
Scientific
HSRG, General practice and Primary Care Research Unit
Department of Public Health and Primary Care
University of Cambridge
Forvie Site
Robinson Way
Cambridge
CB2 2SR
United Kingdom
| Phone | +44 (0)1223 330322 |
|---|
Study information
| Study design | Randomised controlled trial |
|---|---|
| Primary study design | Interventional |
| Secondary study design | Randomised controlled trial |
| Study setting(s) | Not specified |
| Study type | Not Specified |
| Scientific title | |
| Study objectives | To evaluate a Hospital at Home (HAH) service for palliative care. Research questions: 1. Compared to standard care 1.1. Was quality of care better under HAH care? 1.2. Were patients more likely to die at home under HAH care? 1.3. Was pattern of other NHS service use different for patients under HAH care? 2. What were health professionals¿ views of HAH? 3. Did the characteristics and care pathways of HAH patients differ from that of other patients? 4. What were the support needs of patients with lung and colorectal cancer who were likely to become eligible for HAH support? HAH is a service which offers up to 24 hour hands on nursing care in the home, under the medical supervision of the GP, for up to two weeks for adult terminal patients of all diagnoses. It also offers respite care for patients with cancer, MND and AIDS. Factors of interest were place of death, assessment of patient benefits and quality of care under HAH, characteristics and care pathways of patients referred to HAH. |
| Ethics approval(s) | Not provided at time of registration |
| Health condition(s) or problem(s) studied | Symptoms and general pathology: Pain |
| Intervention | 1. Individual Randomised Controlled Trial (RCT) of HAH care versus standard care 2. Survey of health professionals¿ views of HAH, based on pilot study semi-structured interviews 3. Record linkage of electronic data from Cancer Registry, primary and secondary care databases to assess: 3.1. Service use under HAH care versus standard care (incorporated into RCT) 3.2. The characteristics and care pathways of patients referred to HAH versus those not referred 4. Prospective, longitudinal study of colorectal and lung cancer patients eligible for HAH care, and their family carers, beginning when patient care switched from curative to palliative according to hospital |
| Intervention type | Other |
| Primary outcome measure | 1. Randomised controlled trial: place of death, rated symptom severity and adequacy of care, GP visits, care input from NHS primary and secondary care services during the last two weeks of life 2. Survey: ratings of the importance, benefits and disadvantages of HAH 3. Record linkage: demographic and clinical variables (age, sex, socio-economic status, survival, diagnosis, cause of death), service input variables (contact with oncology services, amount and start date of primary and secondary care NHS input in the last year of life) 4. Longitudinal study: prospective and retrospective expressed need and satisfaction with care, activities of daily living, contacts with health professionals, standard measures of health and quality of life (SF-36, EORTC QLQ-C30), and carer strain (CADI) |
| Secondary outcome measures | Not provided at time of registration |
| Overall study start date | 01/04/1995 |
| Completion date | 31/12/1999 |
Eligibility
| Participant type(s) | Patient |
|---|---|
| Age group | Other |
| Sex | Both |
| Target number of participants | 229 |
| Key inclusion criteria | 1. 186 palliative care patients allocated to HAH and 43 palliative control patients. Comparison between HAH and standard care including both primary and secondary NHS input 2. Survey: 78 community nurses, 136 GPs. Assessment of community care only 3. Record linkage: 121 cancer patients referred to HAH, 206 cancer patients not referred to HAH. Both primary and secondary NHS input included 4. Longitudinal study: 54 lung cancer patients, 46 colorectal cancer patients. Both primary and secondary NHS input included. |
| Key exclusion criteria | Does not match inclusion criteria |
| Date of first enrolment | 01/04/1995 |
| Date of final enrolment | 31/12/1999 |
Locations
Countries of recruitment
- England
- United Kingdom
Study participating centre
HSRG, General practice and Primary Care Research Unit
Cambridge
CB2 2SR
United Kingdom
CB2 2SR
United Kingdom
Sponsor information
Record Provided by the NHS R&D 'Time-Limited' National Programme Register - Department of Health (UK)
Government
Government
The Department of Health
Richmond House
79 Whitehall
London
SW1A 2NL
United Kingdom
| Website | http://www.doh.gov.uk |
|---|
Funders
Funder type
Government
NHS Primary and Secondary Care Interface National Research and Development Programme (UK)
No information available
Results and Publications
| Intention to publish date | |
|---|---|
| Individual participant data (IPD) Intention to share | No |
| IPD sharing plan summary | Not provided at time of registration |
| Publication and dissemination plan | Not provided at time of registration |
| IPD sharing plan |
Study outputs
| Output type | Details | Date created | Date added | Peer reviewed? | Patient-facing? |
|---|---|---|---|---|---|
| Results article | results | 04/12/1999 | Yes | No |
